|
|
Article: Vaccine maker reports net loss of $3.2M in second quarter.
- Article from:
- Health & Medicine Week
- Article date:
- August 18, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc., (AVAN) reported financial results for the second quarter ended June 30, 2003.
The company reported a net loss of $3.2 million, or $.05 per share, for the second quarter of 2003 compared to a net loss of $5.2 million, or $.09 per share, for the second quarter of 2002. The decreased loss for the second quarter of 2003 results primarily from an increase in revenue and a decrease in operating expense compared to the same period in 2002, offset in part by a decrease in investment income.
The increase in revenue of $435,600, or 67.8%, primarily reflects revenue of $818,600 recognized ...
Related newspaper, magazine, and journal articles:
|